Haneef Ahmed Amissah

Mr. Haneef Ahmed Amissah

Circulatory Physiology and Molecular Pathology, Okayama University, Okayama, Japan
orcid
Molecular Biologist

Biography

Haneef Ahmed Amissah, Medical Laboratory Technologist, is a trained Molecular Biologist and currently a MEXT Scholar pursuing his Ph.D at the Department of Medical Laboratory Science, Okayama University, Okayama, Japan. He recieved my B.Sc. in Medical Laboratory Technolocy from the University of Cape Coast, Ghana, and his M.Sc. in Biology (Molecular and Cell Biology Specialization) from the Far Eastern Federal University, Vladivostok, Russia, where he completed a thesis titled "3D Experimental Model of Extracellular Matrix for Investigating Glioma Cell Migration and Invasion." He is now undertaking doctoral studies in Molecular Pathology. His research integrates genetics, animal and cell culture models, and molecular approaches to understand how proteases (such as ADAMTS-1) and Heat Shock Protein (HSP)-driven ECM remodelling shape physiological and cancer progression. Through these studies, he aims to unravel and bridge fundamental mechanisms of ECM dynamics with translational applications for novel therapy strategies.

Affiliations

Okayama University

Okayama, Japan

Circulatory Physiology and Molecular Pathology

Honors and Awards

honor

Departmental Best Graduate (Master's Degree) Research Work

Far Eastern Federal University

Awarded the best graduate research work for my research project on "3D Experimental Model of Extracellular Matrix for Investigating Glioma Cell Migration and Invasion."

honor

Departmental Best Graduate Student

Far Eastern Federal University

Awarded the best graduate student for attaining the highest CGPA.

honor

MEXT Scholar

Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan

Experience

Graduate Student or Post Graduate

Okayama University, Okayama, Japan

01 Oct 2025 - present

Graduate Student or Post Graduate

Far Eastern Federal University, Vladivostok, Russia

01 Nov 2022 - 01 Jul 2024